Free

Better than a weekend tummy tuck…

Inamed (IMDC) , a company I first wrote about 4 years ago back at Crain’s New York Business, has done well by its shareholders, largely because its products, which focus on plastic surgery and obesity, have been in hot demand. But something in Inamed’s proxy, filed earlier today, shows that breasts aren’t the only things being augmented. The son-in-law of director Malcolm Currie received twice as much in “marketing and consulting” fees as he did in 2002. The proxy doesn’t name the son-in-law, his company, nor what services it provided that were worth $1.4 million in 2003. In 2002, the company paid the son-in-law $700,000, according to the 2002 proxy. Currie, who sits on several other boards of publicly traded companies, including LSI Logic (LSI) , and who runs his own private company, Currie Tech, is chairman of Inamed’s audit committee and its largest insider shareholder.